Cross-reactive neutralizing antibody responses elicited by SARS-CoV-2 501Y.V2 (B.1.351)

dc.contributor.authorMoyo‑Gwete, Thandeka
dc.contributor.authorMadzivhandila, Mashudu
dc.contributor.authorMakhado, Zanele
dc.contributor.authorAyres, Frances
dc.contributor.authorMhlanga, Donald
dc.contributor.authorOosthuysen, Brent
dc.contributor.authorLambson, Bronwen E.
dc.contributor.authorKgagudi, Prudence
dc.contributor.authorTegally, Houriiyah
dc.contributor.authorIranzadeh, Arash
dc.contributor.authorDoolabh, Deelan
dc.contributor.authorTyers, Lynn
dc.contributor.authorChinhoyi, Lionel R.
dc.contributor.authorMennen, Mathilda
dc.contributor.authorSkelem, Sango
dc.contributor.authorMarais, Gert
dc.contributor.authorWibmer, Constantinos K.
dc.contributor.authorBhiman, Jinal N.
dc.contributor.authorUeckermann, Veronica
dc.contributor.authorRossouw, Theresa M.
dc.contributor.authorBoswell, Michael T.
dc.contributor.authorDe Oliveira, Tulio
dc.date.accessioned2022-11-01T13:08:48Z
dc.date.available2022-11-01T13:08:48Z
dc.date.issued2021-06
dc.description.abstractNo abstract available.en_US
dc.description.departmentInternal Medicineen_US
dc.description.librarianam2022en_US
dc.description.sponsorshipThe South African Medical Research Council, the Centers for Disease Control and Prevention, the ELMA South Africa Foundation, the Wellcome Trust, the Fogarty International Center of the National Institutes of Health, the FLAIR Fellowship program, the European and Developing Countries Clinical Trials Partnership 2 of the European Union Horizon 2020 program, the South African Research Chairs Initiative of the Department of Science and Innovation and the National Research Foundation.en_US
dc.description.urihttp://www.nejm.orgen_US
dc.identifier.citationMoyo‑Gwete, T., Madzivhandila, M., Makhado, Z. et al. 2021, 'Cross-reactive neutralizing antibody responses elicited by SARS-CoV-2 501Y.V2 (B.1.351)', New England Journal of Medicine, vol. 384, pp. 2161-2163, doi : 10.1056/NEJMc2104192.en_US
dc.identifier.issn0028-4793 (print)
dc.identifier.issn1533-4406 (online)
dc.identifier.other10.1056/NEJMc2104192
dc.identifier.urihttps://repository.up.ac.za/handle/2263/88065
dc.language.isoenen_US
dc.publisherMassachusetts Medical Societyen_US
dc.rights© 2021 Massachusetts Medical Society.en_US
dc.subjectMutationsen_US
dc.subjectPatientsen_US
dc.subjectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)en_US
dc.subjectSouth Africa (SA)en_US
dc.titleCross-reactive neutralizing antibody responses elicited by SARS-CoV-2 501Y.V2 (B.1.351)en_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
MoyoGwete_CrossReactive_2021.pdf
Size:
405.4 KB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.75 KB
Format:
Item-specific license agreed upon to submission
Description: